Compound 903
Identifiers
- Canonical SMILES:
Cn1ncc2c1nc(-c1cccc(c1)C(F)(F)F)c1c2[nH]n(-c2ccc(cc2)C(=O)N2CCCC2)c1=O
- InChi:
InChI=1S/C26H21F3N6O2/c1-33-23-19(14-30-33)22-20(21(31-23)16-5-4-6-17(13-16)26(27,28)29)25(37)35(32-22)18-9-7-15(8-10-18)24(36)34-11-2-3-12-34/h4-10,13-14,32H,2-3,11-12H2,1H3
- InChiKey:
WSADUZHNAOLJAB-UHFFFAOYSA-N
External links
168318028 |
External search
Bibliography (1)
Pharmacological data
Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|
1 | 0 | 0 | 0 |
Targets
PPI family | Best activity | Diseases | MMoA |
---|---|---|---|
CD80 / CD28 | 6.96 | cancer | Inhibition |
Physicochemical filters
Descriptor | Lipinski's RO5 | Veber | Pfizer's 3/75 | |
---|---|---|---|---|
Compliance | ||||
MW | 506.17 g/mol | |||
HBA | 8 | |||
HBD | 1 | |||
HBA + HBD | 9 | |||
AlogP | 4.70 | |||
TPSA | 83.36 | |||
RB | 4 |
Radar chart
PCA : iPPI-DB chemical space
PCA : Correlation circle
Efficiencies: iPPI-DB biplot LE versus LLE
Summary
Bibliographic ressources | Biochemical tests | Cellular tests | PK tests | Cytotoxicity tests |
---|---|---|---|---|
1 | 1 | 0 | 0 | 0 |
Ta | Structure | Name | Drugbank ID |
---|---|---|---|
0.5062 | N-cyclopropyl-3-{[1-(2,4-difluorophenyl)-7-methyl-6-oxo-6,7-dihydro-1H-pyrazolo[3,4-b]pyridin-4-yl]amino}-4-methylbenzamide | DB08349 | |
0.4783 | Ispinesib | DB06188 | |
0.4758 | Riociguat | DB08931 | |
0.4749 | MK-0249 | DB11910 | |
0.4733 | Risdiplam | DB15305 | |
0.4689 | 6-CHLORO-9-HYDROXY-1,3-DIMETHYL-1,9-DIHYDRO-4H-PYRAZOLO[3,4-B]QUINOLIN-4-ONE | DB07218 | |
0.4681 | ATX-914 | DB12673 | |
0.4667 | Tepotinib | DB15133 | |
0.4633 | Merestinib | DB12381 | |
0.4609 | Vericiguat | DB15456 | |
0.4589 | ABT-288 | DB15192 | |
0.4564 | Dilmapimod | DB12140 | |
0.4558 | 5-(2-fluorophenyl)-N-(pyridin-4-ylmethyl)pyrazolo[1,5-a]pyrimidin-7-amine | DB08534 | |
0.4522 | (1S,3R,6S)-4-oxo-6-{4-[(2-phenylquinolin-4-yl)methoxy]phenyl}-5-azaspiro[2.4]heptane-1-carboxylic acid | DB07189 | |
0.4511 | Decoglurant | DB11923 |